About
Small Molecules Drug Discovery
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
164
By Phase
PHASE2: 2PHASE1: 3
By Status
COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06469853Lead Sponsor
Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of MBF-015 in Huntington's Disease Patients
PHASE2Completed
10 participants
Started: Feb 1, 2024 · Completed: Dec 4, 2024
NCT05940558Lead Sponsor
Safety and Efficacy of MBF-118 in Patients with Crohn Disease
PHASE2Completed
10 participants
Started: Apr 12, 2023 · Completed: Sep 10, 2024
NCT05940571Lead Sponsor
First Phase Clinical Trial of Single Agent MBF-362 in Solid Tumors
PHASE1Completed
16 participants
Started: Nov 24, 2022 · Completed: Jan 16, 2025
NCT06049147Lead Sponsor
Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers
PHASE1Completed
72 participants
Started: Jul 7, 2021 · Completed: Aug 24, 2023
NCT05921916Lead Sponsor
Study to Assess the Safety and Tolerability of MBF-118 in Healthy Volunteers
PHASE1Completed
56 participants
Started: Jul 3, 2020 · Completed: Sep 6, 2022
Locations (1)
Headquarters
Navarrra, Spain
Map
Loading map...